Recon: Teva Wins Ruling Tossing $235M GSK Verdict

• Unum IPO hits bottom of range, netting $62M for cell therapy cancer trials (Fierce) (Endpoints)
• Teva Wins Ruling Tossing $235 Million Glaxo Drug Verdict (Bloomberg) (Reuters)
• Fired VA Secretary Says White House Muzzled Him (NPR) (NYT) (CBS News) (CNBC)
• Faced with fresh concerns about Hemlibra’s safety, Roche spells out what it knows about 5 deaths (Endpoints) (Fierce)
• CNBC interview with Scott Gottlieb (Transcript)
• MediciNova's repurposed stroke drug flops in methamphetamine dependence trial (Fierce) (Endpoints)

• EU ready to review Shire’s lanadelumab for HAE (PharmaTimes) (PMLive) (The Pharma Letter)
• Fujifilm to buy two biotech units from JXTG for $800 million (Reuters) (Endpoints)
• Indivior inks deal for preclinical addiction treatment candidate (BioPharma Dive) (Fierce)
• Redx Pharma calls a temporary halt to cancer trial to look at patient dosing (Fierce) (Endpoints)
• France to spend 1.5 billion euros on artificial intelligence by 2022 (Reuters)
• Summary record: technical expert seminar on pharmaceuticals related matters following UK withdrawal (EC) (EC)
• First case of super-resistant gonorrhea reported (CNN) (BBC News) (Newsweek)

• Health-Care M&A Balloons in Busiest Start in More Than a Decade (Bloomberg)
• Pharma Middlemen Have Targets On Their Backs (Forbes)
• PhRMA goes after drug 'middlemen' in new ad attack (BioPharma Dive)
• Bristol-Myers CEO Giovanni Caforio nets $18.7M in 2017 pay, a 10% raise (Fierce)
• Washington state has the first comprehensive drug take-back program. Which state will be next? (STAT-$)
• This Company Beat the Odds to Become One of the World's Most 'Innovative' Drug Giants (Fortune)
• As Saline Shortages Persist, Providers Pin Hopes On Feds Demanding Backup Manufacturing Capacity (Pink Sheet)
• Vermont transparency pricing law may show big price hikes, but disappoints lawmakers (STAT-$)
• Judge OKs Drug Distributor Info Sharing In Opioid MDL (Law360-$)
• Why pharma companies need to upgrade their intelligence (pharmaphorum)

• Celgene-partnered Forma teams with Arpeggio to understand drug-target interactions (Fierce)
• Pfizer Announces Positive Topline Results From Phase 3 ATTR-ACT Study Of Tafamidis In Patients With Transthyretin Cardiomyopathy (Press)
• Denali-WashU team clears Alzheimer’s plaques in mice by targeting a faulty APOE gene (Fierce)
• Scientists find mini gastrointestinal tract growing inside tumor (STAT)
• CAR-T is a personalized attack on cancer. Here’s how it works (STAT-$)
• Final results from landmark DYNAGITO trial published in The Lancet Respiratory Medicine (Press)
• Five Prime Therapeutics Initiates Patient Dosing in Phase 1 Trial of Novel First-in-Class B7-H4 Antibody FPA150 (Press)

• Zimmer Biomet touts 7-year results in Mobi-C cervical disc trial (MassDevice)
• LivaNova launches Microburst VNS drug-resistant epilepsy trial (MassDevice)
• Scientists Say They Have Developed A Memory-Restoring Prosthetic For The Human Brain (Forbes)
• Bard Exec Defends Handling Of Complaints At Vein Filter Trial (Law360-$)
• Essure Users Must Combine 13K Injury Suits, Judge Says (Law360-$)
• Abbott Initiates Trial to Evaluate Improved Survival And Outcomes with the CardioMEMS Monitor (Press)
• Institut Curie and Freenome Announce a Strategic Collaboration in Cell-Free DNA Analysis Using Machine Learning Technology (Press)
• IlluminOss Medical Executive Chairwoman Martha Shadan Named Chair of AdvaMed Accel (AdvaMed)
• FDA Panel to Review Implanted 90-Day Glucose Monitor (MedPage Today)

• Dems seek to flank Trump on drug prices (The Hill)
• Rite Aid-Albertsons Deal Clears Key U.S. Antitrust Hurdle (Forbes)
• House lawmakers hope to bring opioid legislation to vote before Memorial Day (STAT)
• The government wants to free your health data. Will that unleash innovation? (STAT)
• ‘My first reaction was OMG’: Trump’s VA pick is new to all this (Politico)
• The antitrust case against new insurance mergers (Axios)
• Pharmacies Again Sue Express Scripts After Talks Fail (Law360-$)
• Walgreens Readies New Store Formats As Amazon And CVS Loom (Forbes)
• Docs, Medical Boards Ignored FDA Warning Letters on CCSVI (MedPage Today)
• Federal Circuit Issues Stay in St. Regis Mohawk Tribe Sovereign Immunity Appeal (Patent Law Weblog)
• Center for Biologics Evaluation and Research within the Food and Drug Administration is seeking qualified candidates to serve as the Director, Office of Blood Research and Review (FDA)
• Federal judge approves consent decree with New York dietary supplement manufacturer Riddhi USA (FDA)

• FDA Advisory Committee Calendar

• Building Cooperation in Cross-border Healthcare: New study maps state of play and optimal ways forward (EC)
• LivaNova Bicarbon Aortic Valves Receive CE Mark for Expanded Use Labeling with Lower-Dose Blood Thinners in Low-Risk Patients (Press)
• NHS England frees up millions of pounds which could be used for frontline services (NHS England)
• Interested in responsible gene editing? Join the (new) club (Science Magazine)
• Batch recall – Reminyl Prolonged Release Kapseln, 8 mg (Swissmedic)

• With ‘Moneyball’ for Health Care, Israel Seeks Edge in Tech Age (Bloomberg)
• Why empathy is crucial to transform Asia’s healthcare (GovInsider)

• Government should fund healthcare sector, promote local industries: Dr Bindra (Times of India)

• Inaugural Industry Forum on Good Manufacturing Practice (GMP) (TGA)
• Australia's healthcare sector has been on a hiring frenzy (Business Insider)
• Application for an evaluation of a new complementary medicine substance (TGA)
• Consultation: Draft therapeutic goods advertising code 2018 and associated guidelines (TGA)
• Mandatory requirements for an effective registered complementary medicine application (TGA)
• Medical device industry calls for My Health Record to include medical device data (MTAA)

• Updated Notice: eCTD Pilot for Clinical Trial Regulatory Activities – Extension (Health Canada)
• Cogstate Receives Health Canada Marketing Authorization for Latest Healthcare Offering (Press)
• BioMarker Strategies Announces that Both of Its Core Diagnostics Technologies for Solid Tumor Cancers Are Now Covered by New Patents Granted in Canada (Press)
• Acerus expands its urology franchise (The Pharma Letter-$)

• Millions have been traumatized by female genital mutilation. The practice must end (STAT)
• It only feels like we’re paying more for health care (Axios)
• Genetic Testing: Do You Really Want to Know? (WebMD)
• A Radical Solution For Saving America's Hospitals (Forbes)